Autoimmune

Disease

Related News

Clinical Trial Costs and Phases: From Safety Testing to Market Approval

Clinical trials take 10-15 years and cost $1-2 billion from discovery to approval, progressing through four phases from safety testing to real-world monitoring. These studies face challenges including high costs, regulatory oversight, and participant recruitment while new technologies are transforming trial design. Illinois faces a shortage of Phase I clinical trial facilities despite local companies conducting over 50 such trials annually.

Related Clinical Trials

NCT ID Title Status Phase
NCT07291323

Study of JANX011 in Healthy Adult Volunteers to Assess Safety and Tolerability.

RECRUITING EARLY_PHASE1
NCT07144462

A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases

RECRUITING EARLY_PHASE1
NCT06626919

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

RECRUITING PHASE1
NCT05984316

Systemic Lupus Erythematosus

RECRUITING NA
NCT05866861

A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus

ACTIVE_NOT_RECRUITING PHASE1
NCT05697159

7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis

RECRUITING
NCT04872257

Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo

COMPLETED NA
NCT04618575

Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1

UNKNOWN PHASE4
NCT03771768

Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease

UNKNOWN NA
NCT03461419

Use of Stromal Vascular Fraction in Multiple Sclerosis

SUSPENDED NA